A better way to solve a crisis: A new mechanism for incentivising R&D on...

Antimicrobial resistance is the ‘silent’ pandemic: Globally, it costs 5 million lives a year, and is set to rise to more than 8 million...
INB co-chairs, Precious Matsoso from South Africa and Roland Driece from the Netherlands opening the session on 18 June

Seven recommendations for sharing intellectual property, know-how and technology – report of Global Expert...

Negotiators of a Pandemic Treaty should heed the recommendations, published 15 July in the BMJ Global Health, to design a fair global system for...

The European Commission says Covid-19 vaccines should be global public goods, but do their...

The European Commission has entered into advance purchase agreements (APAs) for Covid-19 vaccines with six pharmaceutical companies and is concluding negotiations with two companies....

WHO’s Essential Medicines Committee takes aim at rising prices, adds new treatments for cancer...

On 1 October, the World Health Organization published its latest Model List of Essential Medicines (EML) and Essential Medicines for Children (EMLc). Updated roughly...

Gilead’s sofosbuvir patent in India – options for global access to new hepatitis C...

Earlier this month the US pharmaceutical company Gilead obtained a patent in India for sofosbuvir, part of a treatment of hepatitis C that became...

The new EU compulsory licensing regime needs to allow the export of medicines

Guest author Olga Gurgula is a Senior Lecturer in Intellectual Property Law at Brunel Law School, Brunel University London. A war-weary Ukraine critically depends on the support of...

WHO is an essential forum for debates on intellectual property and public health

Recently, Health Policy Watch reported that some European countries at the World Health Organization (WHO) Pandemic Agreement negotiations maintain that intellectual property negotiations belong...

What is the ‘know-how gap’ problem and how might it impact scaling up production...

This entire article is also available as a PDF by clicking here. 1. Introduction. How relevant are concerns about intellectual property rights causing problems for...

Medicines Law & Policy’s director, Ellen ’t Hoen, receives high Netherlands honour for her...

Ellen 't Hoen has been appointed Officer of the Order of Oranje-Nassau, a royal award which recognises those who merit particular appreciation from society...

The Urgency of Compulsory Licensing Provision for Transfer of Technology in the Pandemic Treaty:...

Guest blog by Ronald Eberhard The Intergovernmental Negotiating Body, established by the World Health Assembly, aims to draft a global pandemic prevention, preparedness, and response...